Teva Argues Feds Should Be Held to Higher Standard on Patient Assistance Cases

The U.S. government should have to prove that the claims in False Claims Act (FCA) kickback cases would not have been submitted “but for” kickbacks, says Teva Pharmaceuticals in response its latest to a years-long back-and-forth with the Department of Justice (DOJ).
Source: Drug Industry Daily